Monash Ivf Group Ltd - Asset Resilience Ratio

Latest as of December 2025: 1.60%

Monash Ivf Group Ltd (MVF) has an Asset Resilience Ratio of 1.60% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check MVF strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$8.14 Million

≈ $5.76 Million USD Cash + Short-term Investments

Total Assets

AU$510.21 Million

≈ $361.01 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Monash Ivf Group Ltd's Asset Resilience Ratio has changed over time. See MVF equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Monash Ivf Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Monash Ivf Group Ltd (MVF) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$8.14 Million	1.6%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$8.14 Million	1.60%

Asset Resilience Insights

Limited Liquidity: Monash Ivf Group Ltd maintains only 1.60% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Monash Ivf Group Ltd Industry Peers by Asset Resilience Ratio

Compare Monash Ivf Group Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%

Annual Asset Resilience Ratio for Monash Ivf Group Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Monash Ivf Group Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	0.11%	AU$543.00K ≈ $384.21K	AU$492.61 Million ≈ $348.55 Million	-0.30pp
2024-06-30	0.41%	AU$2.06 Million ≈ $1.46 Million	AU$508.47 Million ≈ $359.77 Million	-0.01pp
2023-06-30	0.41%	AU$1.75 Million ≈ $1.23 Million	AU$421.89 Million ≈ $298.52 Million	+0.16pp
2022-06-30	0.25%	AU$967.00K ≈ $684.21K	AU$387.10 Million ≈ $273.90 Million	-0.24pp
2021-06-30	0.49%	AU$1.75 Million ≈ $1.24 Million	AU$356.17 Million ≈ $252.02 Million	-0.07pp
2020-06-30	0.57%	AU$2.00 Million ≈ $1.42 Million	AU$354.22 Million ≈ $250.64 Million	+0.37pp
2019-06-30	0.19%	AU$565.00K ≈ $399.77K	AU$290.04 Million ≈ $205.22 Million	+0.00pp
2018-06-30	0.19%	AU$565.00K ≈ $399.77K	AU$290.61 Million ≈ $205.63 Million	0.00pp
2017-06-30	0.20%	AU$565.00K ≈ $399.77K	AU$287.25 Million ≈ $203.25 Million	--

pp = percentage points

About Monash Ivf Group Ltd

AU:MVF Australia Diagnostics & Research

Market Cap

$202.63 Million

AU$286.38 Million AUD

Market Cap Rank

#16596 Global

#469 in Australia

Share Price

AU$0.74

Change (1 day)

+5.76%

52-Week Range

AU$0.59 - AU$0.88

All Time High

AU$1.65